Keros Therapeutics, Inc.
← Back to KROS Overview

Keros Therapeutics, Inc. (KROS)

Price-to-Earnings Ratio History

P/E Ratio (TTM)

-8.08

Financial Fundamentals

KROSQuarterly Data • 5Y View

Quarterly P/E

QuarterP/E Ratio
2019-03-31-14.01
2019-06-30-15.63
2019-09-30-12.56
2019-12-31-16.21
2020-03-31-7.68
2020-06-30-15.36
2020-09-30-16.16
2020-12-31-35.72
2021-03-31-22.50
2021-06-30-15.84
2021-09-30-11.38
2021-12-31-49.39
2022-03-31-13.49
2022-06-30-6.09
2022-09-30-10.22
2022-12-31-11.04
2023-03-31-8.46
2023-06-30-7.93
2023-09-30-6.00
2023-12-31-7.44
2024-03-31-11.42
2024-06-30-8.73
2024-09-30-9.90
2024-12-31-3.47
2025-03-310.70
2025-06-30-4.42
2025-09-30-22.07
2025-12-31-8.08

* P/E ratios are calculated using trailing twelve-month (TTM) earnings.